Neurocrine Biosciences
NBIX
#1498
Rank
$14.35 B
Marketcap
$141.25
Share price
-1.55%
Change (1 day)
1.56%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company